ImpediMed develops advanced medical products which utilize bioimpedance spectroscopy technology, or BIS. ImpediMed’s BIS devices apply a very low-level alternating electrical current to the body and measure impedance at 256 different frequencies over a full spectrum from 3 kHz to 1000 kHz to fully characterize the conductive and nonconductive tissue and fluid components of the body.
Raise awareness of the tough challenges faced by actual breast cancer patients with lymphedema.
Dr. Stanley G. Rockson, Director, Stanford Center for Lymphatic and Venous Disorders, Stanford University, discusses issues related to early assessment of lymphedema and the clinical utility of bioimpedance spectroscopy (BIS).
Associate Professor Ward has utilised bioimpedance spectroscopy (BIS) to develop an accurate yet inexpensive tool for early detection of lymphedema, the accumulation of excessive amounts of protein-rich fluid resulting in swelling of one or more regions of the body, due to a mechanical failure of the lymphatic system.